The outcome of fertility preservation treatment in JAPAN (2021)

The outcome of Embryo and oocyte and ovarian tissue in JAPAN (2021) - The outcome of Embryo and oocyte and ovarian tissue in JAPAN (2021)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043664

Enrollment

1000

Registered

2021-04-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, hematological cancer, and so on

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patient who underwent embryo, oocyte, or ovarian tissue cryopreservation as fertility preservation treatment.

Exclusion criteria

Exclusion criteria: The patients who decline to contribute the present study.

Design outcomes

Primary

Measure	Time frame
Live birth rate	—

Secondary

Measure	Time frame
pregnancy rate, the numbers of extracted oocyte, and so on.	—

Countries

Japan

Contacts

Public ContactSEIDO TAKAE

St. Marianna University School of Medicine Obstetrics and Gynecology

s2takae@marianna-u.ac.jp044-977-8111

Outcome results